KA/EN
Register
Medicines reference
Search
Search
Product

Ciprovet

Favourites

Ciprofloxacin hydrochloride · AVZ S-P Ltd

2 forms: tablet. In force in Georgia: 2 of 2 (veterinary register).

Forms and doses2 of 2 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Choose species and weight; the matching row will be highlighted.
Form Species Weight Dose Frequency Georgia
15 mg tablets, Tablet · Cat up to 3 kg Cat up to 3 kg 1 tablet
Prescription antimicrobial. Use only for a susceptible bacterial or mycoplasmal infection under veterinary direction. Do not use with quinolone hypersensitivity, marked cartilage/bone-development disorder, seizure-associated neurologic disease, pregnancy or lactation; not for kittens below 6 months, puppies below 12 months, or large-breed puppies below 18 months. Do not combine with chloramphenicol, macrolides, tetracyclines, theophylline, NSAIDs, or magnesium/aluminium/calcium-containing products.
 · once daily for 3-5 days		 once daily for 3-5 days Georgia Yes, veterinary
In force until 21 May 2029
Veterinary (National Food Agency)
In the register: ციპროვეტი® ტაბლეტები კატებისა და პატარა ჯიშის ძაღლებისთვის
№ 000610
Verified on: 21 Oct 2026
15 mg tablets, Tablet · Cat 3–6 kg Cat 3–6 kg 2 tablets
Prescription antimicrobial. Use only for a susceptible bacterial or mycoplasmal infection under veterinary direction. Do not use with quinolone hypersensitivity, marked cartilage/bone-development disorder, seizure-associated neurologic disease, pregnancy or lactation; not for kittens below 6 months, puppies below 12 months, or large-breed puppies below 18 months. Do not combine with chloramphenicol, macrolides, tetracyclines, theophylline, NSAIDs, or magnesium/aluminium/calcium-containing products.
 · once daily for 3-5 days		 once daily for 3-5 days Georgia Yes, veterinary
In force until 21 May 2029
Veterinary (National Food Agency)
In the register: ციპროვეტი® ტაბლეტები კატებისა და პატარა ჯიშის ძაღლებისთვის
№ 000610
Verified on: 21 Oct 2026
15 mg tablets, Tablet · Cat 6–10 kg Cat 6–10 kg 3 tablets
Prescription antimicrobial. Use only for a susceptible bacterial or mycoplasmal infection under veterinary direction. Do not use with quinolone hypersensitivity, marked cartilage/bone-development disorder, seizure-associated neurologic disease, pregnancy or lactation; not for kittens below 6 months, puppies below 12 months, or large-breed puppies below 18 months. Do not combine with chloramphenicol, macrolides, tetracyclines, theophylline, NSAIDs, or magnesium/aluminium/calcium-containing products.
 · once daily for 3-5 days		 once daily for 3-5 days Georgia Yes, veterinary
In force until 21 May 2029
Veterinary (National Food Agency)
In the register: ციპროვეტი® ტაბლეტები კატებისა და პატარა ჯიშის ძაღლებისთვის
№ 000610
Verified on: 21 Oct 2026
15 mg tablets, Tablet · Dog up to 3 kg Dog up to 3 kg 1 tablet
Prescription antimicrobial. Use only for a susceptible bacterial or mycoplasmal infection under veterinary direction. Do not use with quinolone hypersensitivity, marked cartilage/bone-development disorder, seizure-associated neurologic disease, pregnancy or lactation; not for kittens below 6 months, puppies below 12 months, or large-breed puppies below 18 months. Do not combine with chloramphenicol, macrolides, tetracyclines, theophylline, NSAIDs, or magnesium/aluminium/calcium-containing products.
 · once daily for 3-5 days		 once daily for 3-5 days Georgia Yes, veterinary
In force until 21 May 2029
Veterinary (National Food Agency)
In the register: ციპროვეტი® ტაბლეტები კატებისა და პატარა ჯიშის ძაღლებისთვის
№ 000610
Verified on: 21 Oct 2026
15 mg tablets, Tablet · Dog 3–6 kg Dog 3–6 kg 2 tablets
Prescription antimicrobial. Use only for a susceptible bacterial or mycoplasmal infection under veterinary direction. Do not use with quinolone hypersensitivity, marked cartilage/bone-development disorder, seizure-associated neurologic disease, pregnancy or lactation; not for kittens below 6 months, puppies below 12 months, or large-breed puppies below 18 months. Do not combine with chloramphenicol, macrolides, tetracyclines, theophylline, NSAIDs, or magnesium/aluminium/calcium-containing products.
 · once daily for 3-5 days		 once daily for 3-5 days Georgia Yes, veterinary
In force until 21 May 2029
Veterinary (National Food Agency)
In the register: ციპროვეტი® ტაბლეტები კატებისა და პატარა ჯიშის ძაღლებისთვის
№ 000610
Verified on: 21 Oct 2026
15 mg tablets, Tablet · Dog 6–10 kg Dog 6–10 kg 3 tablets
Prescription antimicrobial. Use only for a susceptible bacterial or mycoplasmal infection under veterinary direction. Do not use with quinolone hypersensitivity, marked cartilage/bone-development disorder, seizure-associated neurologic disease, pregnancy or lactation; not for kittens below 6 months, puppies below 12 months, or large-breed puppies below 18 months. Do not combine with chloramphenicol, macrolides, tetracyclines, theophylline, NSAIDs, or magnesium/aluminium/calcium-containing products.
 · once daily for 3-5 days		 once daily for 3-5 days Georgia Yes, veterinary
In force until 21 May 2029
Veterinary (National Food Agency)
In the register: ციპროვეტი® ტაბლეტები კატებისა და პატარა ჯიშის ძაღლებისთვის
№ 000610
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Ciprovet 15 mg tablets, Tablet

N10 for cats and small-breed dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Full dog label: susceptible bacterial and mycoplasmal infections in small dogs up to 10 kg, one 15 mg tablet per up to about 3 kg once daily for 3-5 days
4.7/10
Weak evidence support
vetman assessment

Ciprovet

15 mg tablets, N10 for cats and small-breed dogs
Assessed clinical scopeDog · Full dog label: susceptible bacterial and mycoplasmal infections in small dogs up to 10 kg, one 15 mg tablet per up to about 3 kg once daily for 3-5 days · By mouth
Care settingVeterinary prescription after diagnosis, ideally with culture and susceptibility testing, for oral treatment at home
vetman score 4.7/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000610 · Verified on 21 Oct 2026

A weak antimicrobial choice for small dogs: a restricted-use fluoroquinolone at a dose well below canine pharmacokinetic targets. Prefer first-line drugs, or an authorised veterinary fluoroquinolone when culture supports one.

Regulatory and scientific credibility4.0/10

The exact product is registered in Georgia (000610, valid to 2029) with a current AVZ instruction, but ciprofloxacin has no EU, UK or US veterinary authorisation documented in the reviewed evidence for dogs and no product study is public.

Clinical efficacy3.5/10

Oral ciprofloxacin is poorly and variably absorbed in dogs; clinical-dog data support 25 mg/kg once daily only for isolates with an MIC up to 0.06 µg/ml, so the labelled 5-10 mg/kg is likely to under-dose many infections.

Safety and tolerability6.0/10

Fluoroquinolones are usually well tolerated in adult dogs; the label excludes growing dogs because of cartilage damage, seizure-prone dogs, pregnancy and lactation, and lists several interactions.

Clinical practicality5.5/10

Whole tablets once daily from a weight table are simple, but dogs of 6-10 kg need three tablets a day and the fixed 3-5 day course is shorter than many infections need.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Do not use in puppies under 12 months, large-breed puppies under 18 months, pregnant or lactating bitches, or dogs with seizure disorders or quinolone hypersensitivity.
  • The labelled 5-10 mg/kg is far below the 25 mg/kg once daily that clinical-dog data need even for highly susceptible isolates; under-dosing risks treatment failure and resistance.
  • Fluoroquinolones are EU AMEG Category B (Restrict): use only when culture and susceptibility show that first-line drugs are unsuitable.
  • Give apart from magnesium, aluminium or calcium products; avoid theophylline and NSAIDs (seizure risk) and the label's listed chloramphenicol, macrolides and tetracyclines.
  • This 15 mg strength is labelled only up to 10 kg; heavier dogs need the 50 mg strength.
Assessment sources
  1. AVZ Ciprovet tablets2026
  2. Georgia NFA register 20262026
  3. Papich 2017 ciprofloxacin PK dogs2017
  4. EMA AMEG 20252025
  5. AAFP/AAHA stewardship2022
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Full cat label: susceptible bacterial and mycoplasmal infections in cats up to 10 kg, one 15 mg tablet per up to about 3 kg once daily for 3-5 days
4.4/10
Weak evidence support
vetman assessment

Ciprovet

15 mg tablets, N10 for cats and small-breed dogs
Assessed clinical scopeCat · Full cat label: susceptible bacterial and mycoplasmal infections in cats up to 10 kg, one 15 mg tablet per up to about 3 kg once daily for 3-5 days · By mouth
Care settingVeterinary prescription after diagnosis, ideally with culture and susceptibility testing, for oral treatment at home
vetman score 4.4/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000610 · Verified on 21 Oct 2026

A weak choice for cats: a restricted-use fluoroquinolone with sparse feline data and a class retinal warning. Doxycycline or amoxicillin-based drugs fit most feline infections better.

Regulatory and scientific credibility4.0/10

The exact product is registered in Georgia (000610, valid to 2029) with a current AVZ instruction, but ciprofloxacin has no EU, UK or US veterinary authorisation documented in the reviewed evidence for cats and no product study is public.

Clinical efficacy3.0/10

Feline pharmacokinetic and clinical data for oral ciprofloxacin are sparse, and feline stewardship guidance prefers doxycycline or amoxicillin-based drugs for common infections, keeping fluoroquinolones for culture-proven need.

Safety and tolerability5.5/10

Fluoroquinolones carry a class warning for retinal damage in cats (shown with enrofloxacin at high doses); the label excludes kittens under 6 months, pregnancy, lactation and seizure disorders.

Clinical practicality5.5/10

Whole tablets once daily are simple to dose, but pilling a cat with up to three tablets a day is demanding and the fixed 3-5 day course is often too short.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Do not use in kittens under 6 months, pregnant or lactating queens, or cats with seizure disorders or quinolone hypersensitivity.
  • Fluoroquinolones can damage the feline retina: stop at once if dilated pupils or vision loss appear, and take extra care with kidney disease.
  • Fluoroquinolones are EU AMEG Category B (Restrict): use only when culture and susceptibility show that first-line drugs are unsuitable.
  • Give apart from magnesium, aluminium or calcium products; avoid theophylline and NSAIDs and the label's listed chloramphenicol, macrolides and tetracyclines.
  • The label table stops at 10 kg; do not extrapolate beyond it.
Assessment sources
  1. AVZ Ciprovet tablets2026
  2. Georgia NFA register 20262026
  3. Feline antimicrobial consensus2025
  4. EMA AMEG 20252025
  5. MSD Vet Manual 20262026
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Ciprofloxacin hydrochloride15 mg
Formulation Type
Tablet
Administration route
By mouth
Manufacturer
AVZ S-P Ltd · Russia
Manufacturer (register)
AVZ S-P Ltd, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1090, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
In force until 21 May 2029
Veterinary (National Food Agency)
In the register: ციპროვეტი® ტაბლეტები კატებისა და პატარა ჯიშის ძაღლებისთვის
№ 000610
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
1 tablet
Prescription antimicrobial. Use only for a susceptible bacterial or mycoplasmal infection under veterinary direction. Do not use with quinolone hypersensitivity, marked cartilage/bone-development disorder, seizure-associated neurologic disease, pregnancy or lactation; not for kittens below 6 months, puppies below 12 months, or large-breed puppies below 18 months. Do not combine with chloramphenicol, macrolides, tetracyclines, theophylline, NSAIDs, or magnesium/aluminium/calcium-containing products.
 Cat up to 3 kg By mouth once daily for 3-5 days
AVZ Ciprovet tablets
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Ciprovet tablets for dogs and cats - current official instruction
Current official manufacturer instruction, 2026
2 tablets
Prescription antimicrobial. Use only for a susceptible bacterial or mycoplasmal infection under veterinary direction. Do not use with quinolone hypersensitivity, marked cartilage/bone-development disorder, seizure-associated neurologic disease, pregnancy or lactation; not for kittens below 6 months, puppies below 12 months, or large-breed puppies below 18 months. Do not combine with chloramphenicol, macrolides, tetracyclines, theophylline, NSAIDs, or magnesium/aluminium/calcium-containing products.
 Cat 3–6 kg By mouth once daily for 3-5 days
AVZ Ciprovet tablets
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Ciprovet tablets for dogs and cats - current official instruction
Current official manufacturer instruction, 2026
3 tablets
Prescription antimicrobial. Use only for a susceptible bacterial or mycoplasmal infection under veterinary direction. Do not use with quinolone hypersensitivity, marked cartilage/bone-development disorder, seizure-associated neurologic disease, pregnancy or lactation; not for kittens below 6 months, puppies below 12 months, or large-breed puppies below 18 months. Do not combine with chloramphenicol, macrolides, tetracyclines, theophylline, NSAIDs, or magnesium/aluminium/calcium-containing products.
 Cat 6–10 kg By mouth once daily for 3-5 days
AVZ Ciprovet tablets
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Ciprovet tablets for dogs and cats - current official instruction
Current official manufacturer instruction, 2026
1 tablet
Prescription antimicrobial. Use only for a susceptible bacterial or mycoplasmal infection under veterinary direction. Do not use with quinolone hypersensitivity, marked cartilage/bone-development disorder, seizure-associated neurologic disease, pregnancy or lactation; not for kittens below 6 months, puppies below 12 months, or large-breed puppies below 18 months. Do not combine with chloramphenicol, macrolides, tetracyclines, theophylline, NSAIDs, or magnesium/aluminium/calcium-containing products.
 Dog up to 3 kg By mouth once daily for 3-5 days
AVZ Ciprovet tablets
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Ciprovet tablets for dogs and cats - current official instruction
Current official manufacturer instruction, 2026
2 tablets
Prescription antimicrobial. Use only for a susceptible bacterial or mycoplasmal infection under veterinary direction. Do not use with quinolone hypersensitivity, marked cartilage/bone-development disorder, seizure-associated neurologic disease, pregnancy or lactation; not for kittens below 6 months, puppies below 12 months, or large-breed puppies below 18 months. Do not combine with chloramphenicol, macrolides, tetracyclines, theophylline, NSAIDs, or magnesium/aluminium/calcium-containing products.
 Dog 3–6 kg By mouth once daily for 3-5 days
AVZ Ciprovet tablets
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Ciprovet tablets for dogs and cats - current official instruction
Current official manufacturer instruction, 2026
3 tablets
Prescription antimicrobial. Use only for a susceptible bacterial or mycoplasmal infection under veterinary direction. Do not use with quinolone hypersensitivity, marked cartilage/bone-development disorder, seizure-associated neurologic disease, pregnancy or lactation; not for kittens below 6 months, puppies below 12 months, or large-breed puppies below 18 months. Do not combine with chloramphenicol, macrolides, tetracyclines, theophylline, NSAIDs, or magnesium/aluminium/calcium-containing products.
 Dog 6–10 kg By mouth once daily for 3-5 days
AVZ Ciprovet tablets
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Ciprovet tablets for dogs and cats - current official instruction
Current official manufacturer instruction, 2026
50 mg tablets, Tablet · Dog 6–10 kg Dog 6–10 kg 1 tablet
Prescription antimicrobial. Use only for a susceptible bacterial or mycoplasmal infection under veterinary direction. Do not use with quinolone hypersensitivity, marked cartilage/bone-development disorder, seizure-associated neurologic disease, pregnancy or lactation; not for kittens below 6 months, puppies below 12 months, or large-breed puppies below 18 months. Do not combine with chloramphenicol, macrolides, tetracyclines, theophylline, NSAIDs, or magnesium/aluminium/calcium-containing products.
 · once daily for 3-5 days		 once daily for 3-5 days Georgia Yes, veterinary
In force until 21 May 2029
Veterinary (National Food Agency)
In the register: ციპროვეტი® ტაბლეტები ძაღლებისთვის
№ 000609
Verified on: 21 Oct 2026
50 mg tablets, Tablet · Dog 10–20 kg Dog 10–20 kg 2 tablets
Prescription antimicrobial. Use only for a susceptible bacterial or mycoplasmal infection under veterinary direction. Do not use with quinolone hypersensitivity, marked cartilage/bone-development disorder, seizure-associated neurologic disease, pregnancy or lactation; not for kittens below 6 months, puppies below 12 months, or large-breed puppies below 18 months. Do not combine with chloramphenicol, macrolides, tetracyclines, theophylline, NSAIDs, or magnesium/aluminium/calcium-containing products.
 · once daily for 3-5 days		 once daily for 3-5 days Georgia Yes, veterinary
In force until 21 May 2029
Veterinary (National Food Agency)
In the register: ციპროვეტი® ტაბლეტები ძაღლებისთვის
№ 000609
Verified on: 21 Oct 2026
50 mg tablets, Tablet · Dog 20–30 kg Dog 20–30 kg 3 tablets
Prescription antimicrobial. Use only for a susceptible bacterial or mycoplasmal infection under veterinary direction. Do not use with quinolone hypersensitivity, marked cartilage/bone-development disorder, seizure-associated neurologic disease, pregnancy or lactation; not for kittens below 6 months, puppies below 12 months, or large-breed puppies below 18 months. Do not combine with chloramphenicol, macrolides, tetracyclines, theophylline, NSAIDs, or magnesium/aluminium/calcium-containing products.
 · once daily for 3-5 days		 once daily for 3-5 days Georgia Yes, veterinary
In force until 21 May 2029
Veterinary (National Food Agency)
In the register: ციპროვეტი® ტაბლეტები ძაღლებისთვის
№ 000609
Verified on: 21 Oct 2026
50 mg tablets, Tablet · Dog 30–40 kg Dog 30–40 kg 4 tablets
Prescription antimicrobial. Use only for a susceptible bacterial or mycoplasmal infection under veterinary direction. Do not use with quinolone hypersensitivity, marked cartilage/bone-development disorder, seizure-associated neurologic disease, pregnancy or lactation; not for kittens below 6 months, puppies below 12 months, or large-breed puppies below 18 months. Do not combine with chloramphenicol, macrolides, tetracyclines, theophylline, NSAIDs, or magnesium/aluminium/calcium-containing products.
 · once daily for 3-5 days		 once daily for 3-5 days Georgia Yes, veterinary
In force until 21 May 2029
Veterinary (National Food Agency)
In the register: ციპროვეტი® ტაბლეტები ძაღლებისთვის
№ 000609
Verified on: 21 Oct 2026
50 mg tablets, Tablet · Dog over 40 kg Dog over 40 kg 1 tablet per every started 10 kg
Prescription antimicrobial. Use only for a susceptible bacterial or mycoplasmal infection under veterinary direction. Do not use with quinolone hypersensitivity, marked cartilage/bone-development disorder, seizure-associated neurologic disease, pregnancy or lactation; not for kittens below 6 months, puppies below 12 months, or large-breed puppies below 18 months. Do not combine with chloramphenicol, macrolides, tetracyclines, theophylline, NSAIDs, or magnesium/aluminium/calcium-containing products.
 · once daily for 3-5 days		 once daily for 3-5 days Georgia Yes, veterinary
In force until 21 May 2029
Veterinary (National Food Agency)
In the register: ციპროვეტი® ტაბლეტები ძაღლებისთვის
№ 000609
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Ciprovet 50 mg tablets, Tablet

N10 for dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
4.8/10
Weak evidence support
vetman assessment

Ciprovet

50 mg tablets, N10 for dogs
Assessed clinical scopeDog · Full dog label: susceptible bacterial and mycoplasmal infections in dogs from 6 kg, ciprofloxacin about 5-10 mg/kg once daily for 3-5 days · By mouth
Care settingVeterinary prescription after diagnosis, ideally with culture and susceptibility testing, for oral treatment at home
vetman score 4.8/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000609 · Verified on 21 Oct 2026

A weak antimicrobial choice: ciprofloxacin is a restricted-use fluoroquinolone, and this label's low dose and short course fit poorly with its variable absorption in dogs. Use first-line drugs where possible and an authorised veterinary fluoroquinolone when culture supports one.

Regulatory and scientific credibility4.0/10

The exact product is registered in Georgia (000609, valid to 2029) with a current AVZ instruction, but ciprofloxacin has no EU, UK or US veterinary authorisation documented in the reviewed evidence for dogs and no product study is public.

Clinical efficacy3.5/10

Ciprofloxacin is a potent class, but oral absorption in dogs is low and variable; a clinical-dog study found that 25 mg/kg once daily covers only isolates with an MIC up to 0.06 µg/ml, so the labelled 5-10 mg/kg is likely to under-dose many infections.

Safety and tolerability6.0/10

Fluoroquinolones are usually well tolerated in adult dogs; the label excludes growing dogs because of cartilage damage, seizure-prone dogs, pregnancy and lactation, and lists several interactions.

Clinical practicality6.0/10

Whole 50 mg tablets once daily from a weight table are simple, but the fixed 3-5 day course is shorter than many infections need and large dogs need many tablets.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Do not use in puppies under 12 months, large-breed puppies under 18 months, pregnant or lactating bitches, or dogs with seizure disorders or quinolone hypersensitivity.
  • The labelled 5-10 mg/kg is far below the 25 mg/kg once daily that clinical-dog data need even for highly susceptible isolates; under-dosing risks treatment failure and resistance.
  • Fluoroquinolones are EU AMEG Category B (Restrict): use only when culture and susceptibility show that first-line drugs are unsuitable.
  • Give apart from magnesium, aluminium or calcium products, which block absorption; avoid theophylline and NSAIDs (seizure risk) and the label's listed chloramphenicol, macrolides and tetracyclines.
  • A 3-5 day course is too short for pyelonephritis, prostatitis or deep pyoderma; set the duration by diagnosis and recheck.
  • This 50 mg strength is not labelled for dogs under 6 kg; the 15 mg strength covers smaller dogs.
Assessment sources
  1. AVZ Ciprovet tablets2026
  2. Georgia NFA register 20262026
  3. Papich 2017 ciprofloxacin PK dogs2017
  4. EMA AMEG 20252025
  5. AAFP/AAHA stewardship2022
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Ciprofloxacin hydrochloride50 mg
Formulation Type
Tablet
Administration route
By mouth
Manufacturer
AVZ S-P Ltd · Russia
Manufacturer (register)
AVZ S-P Ltd, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1089, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
In force until 21 May 2029
Veterinary (National Food Agency)
In the register: ციპროვეტი® ტაბლეტები ძაღლებისთვის
№ 000609
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
1 tablet
Prescription antimicrobial. Use only for a susceptible bacterial or mycoplasmal infection under veterinary direction. Do not use with quinolone hypersensitivity, marked cartilage/bone-development disorder, seizure-associated neurologic disease, pregnancy or lactation; not for kittens below 6 months, puppies below 12 months, or large-breed puppies below 18 months. Do not combine with chloramphenicol, macrolides, tetracyclines, theophylline, NSAIDs, or magnesium/aluminium/calcium-containing products.
 Dog 6–10 kg By mouth once daily for 3-5 days
AVZ Ciprovet tablets
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Ciprovet tablets for dogs and cats - current official instruction
Current official manufacturer instruction, 2026
2 tablets
Prescription antimicrobial. Use only for a susceptible bacterial or mycoplasmal infection under veterinary direction. Do not use with quinolone hypersensitivity, marked cartilage/bone-development disorder, seizure-associated neurologic disease, pregnancy or lactation; not for kittens below 6 months, puppies below 12 months, or large-breed puppies below 18 months. Do not combine with chloramphenicol, macrolides, tetracyclines, theophylline, NSAIDs, or magnesium/aluminium/calcium-containing products.
 Dog 10–20 kg By mouth once daily for 3-5 days
AVZ Ciprovet tablets
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Ciprovet tablets for dogs and cats - current official instruction
Current official manufacturer instruction, 2026
3 tablets
Prescription antimicrobial. Use only for a susceptible bacterial or mycoplasmal infection under veterinary direction. Do not use with quinolone hypersensitivity, marked cartilage/bone-development disorder, seizure-associated neurologic disease, pregnancy or lactation; not for kittens below 6 months, puppies below 12 months, or large-breed puppies below 18 months. Do not combine with chloramphenicol, macrolides, tetracyclines, theophylline, NSAIDs, or magnesium/aluminium/calcium-containing products.
 Dog 20–30 kg By mouth once daily for 3-5 days
AVZ Ciprovet tablets
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Ciprovet tablets for dogs and cats - current official instruction
Current official manufacturer instruction, 2026
4 tablets
Prescription antimicrobial. Use only for a susceptible bacterial or mycoplasmal infection under veterinary direction. Do not use with quinolone hypersensitivity, marked cartilage/bone-development disorder, seizure-associated neurologic disease, pregnancy or lactation; not for kittens below 6 months, puppies below 12 months, or large-breed puppies below 18 months. Do not combine with chloramphenicol, macrolides, tetracyclines, theophylline, NSAIDs, or magnesium/aluminium/calcium-containing products.
 Dog 30–40 kg By mouth once daily for 3-5 days
AVZ Ciprovet tablets
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Ciprovet tablets for dogs and cats - current official instruction
Current official manufacturer instruction, 2026
1 tablet per every started 10 kg
Prescription antimicrobial. Use only for a susceptible bacterial or mycoplasmal infection under veterinary direction. Do not use with quinolone hypersensitivity, marked cartilage/bone-development disorder, seizure-associated neurologic disease, pregnancy or lactation; not for kittens below 6 months, puppies below 12 months, or large-breed puppies below 18 months. Do not combine with chloramphenicol, macrolides, tetracyclines, theophylline, NSAIDs, or magnesium/aluminium/calcium-containing products.
 Dog over 40 kg By mouth once daily for 3-5 days
AVZ Ciprovet tablets
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Ciprovet tablets for dogs and cats - current official instruction
Current official manufacturer instruction, 2026

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 21 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗